LSS - Home

JOIN KEY OPINION LEADERS from industry, academia, medical research foundations, and other major stakeholders who share the goal of bringing new and better therapeutic options to patients faster. The Life Sciences Summit 2011 will explore new paradigms, examine barriers, and think about realigning legacy mind-sets toward a more efficient and productive drug development enterprise. The Program features more than forty-five emerging companies and fifty breakthrough technologies that collectively represent the future of the industry.

PROGRAM HIGHLIGHTS

Emerging Company & Innovators Showcase featuring more than forty next-generation industry leaders including Andarix, Kalos, BREONICS, Acceleron, TechnoVax, Vybion… (more)

Plenary Sessions featuring George Scangos, CEO, Biogen Idec, Shaun Grady, VP Strategic Partnering, AstraZeneca, Greg Wiederrecht, VP, WW Licensing & Ext. Res., Merck, Mary Tanner, Managing Director, Peter J. Solomon Co., Cary Pfeffer, Partner, Third Rock Ventures, Marck Tessier-Lavigne, President, The Rockefeller Univ, Bruce Stillman, President, Cold Spring Harbor Laboratory, Maria Freire, President, Lasker Foundation …(more)

Business Workshops featuring investors and business leaders including Jonathan Fleming, Oxford Bioscience Partners, Louis Berneman, Osage University Partners, Christopher Yochim, Strategic Planning & BD, AstraZeneca, Susan Rohrer, Senior Director, External Scientific Affairs, Merck, Andy Dorner, VP, Millennium…(more)

Translational Research Forum featuring Key Opinion Leaders and academic scientists working in breakthrough areas in oncology, neurology, infectious diseases and regenerative medicine. Arturo Casadevall, Albert Einstein COM, Warren Strittmatter, Duke, Howard Scher, MSKCC, Arnold Caplan, Case Western, …(more)

Collaborate™, an on-line & on-site partnering service to foster new business opportunities, partnerships, and collaborations. Register for the Summit and let the deals begin!

Normal 0 false false false EN-US X-NONE X-NONE

Michael Barbachyn, PhD, Head of External Science, AstraZeneca Pharmaceuticals

Anthony Caggiano, MD, PhD, Vice President, Preclinical Development, Acorda Therapeutics

Arnold Caplan, PhD, Professor of Biology, Professor of General Medical Sciences (Oncology),

Case Western University

Arturo Caplan, PhD, Professor, Chair, Department of Microbiology & Immunology, Department of Medicine, Albert Einstein College of Medicine

Stephen Chang, PhD, New York Stem Cell Foundation

Eva Chmielnicki, PhD, Senior Editor, Research Manuscripts, Nature Medicine

Min Cho, PhD, Associate Editor, Nature Neuroscience

Alonzo D. Cook, PhD, Manager, Technology Assessment, Advanced Technologies and Regenerative Medicine, LLC (ATRM) Johnson & Johnson

Louis J. DeGennaro, PhD, Chief Mission Officer, Executive Vice President, Leukemia and Lymphoma Society

Sheng Ding, PhD, Assistant Professor, Department of Chemistry, Scripps Research Institute

Andy Dorner, PhD, Vice President, Millennium Pharmaceuticals

Howard Fillit, MD, Executive Director, Alzheimer's Drug Discovery Foundation

Gunda Georg, PhD, Professor and Head, Department of Medicinal Chemistry, Director, Institute for Therapeutics Discovery & Development, University of Minnesota

Demetrios L. Kouzoukas, Of Counsel, Covington & Burling LLP

Ram May-Ron, Vice President, FreeMind Group

Jules Mitchel, PhD, President, Target Health Inc.

Iwao Ojima, PhD, Distinguished Professor of Chemistry, Director, Institute for Chemical Biology and Drug Discovery, Stony Brook University

Brock Reeve, MPhil, MBA, Executive Director, Harvard Stem Cell Institute

Susan Rohrer, PhD, Senior Director, External Affairs, Merck & Co., Inc.

Eric K. Rowinsky, MD, Adjunct Professor, New York University

Alan J. Russell, PhD, Founding Director, McGowan Institute for Regenerative Medicine

Edward Saltzman, President, Defined Health

Peter Senter, PhD, Vice President, Chemistry and Distinguished Fellow, Seattle Genetics, Inc.

Andy Shih, PhD, Vice President of Scientific Affairs, Autism Speaks

Barbara S. Slusher, PhD, MBA, Chief Scientific Officer, Brain Science Institute, Johns Hopkins School of Medicine

Bruce Stillman, PhD, President, Cold Spring Harbor Laboratory

Ken Stover, PhD, Senior Director, MedImmune

Marc Tessier-LaVigne, PhD, President and Professor, Laboratory of Brain Development and Repair, The Rockefeller University

Gordana Vunjak-Novakovic, PhD, Professor, Biomedical Engineering, Columbia University

Charles A. Weiss, Partner, Kenyon & Kenyon LLP

Christopher Yochim, Director, Strategic Planning & Business Development, AstraZeneca

LATEST UPDATES

REGISTRATION

2011 SPONSORS